Is Lavipharm SA halal to invest in?

As of August 2026, Lavipharm SA LAVI.AT is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Lavipharm SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lavipharm SA using these criteria to determine its compliance status.

Can Muslims buy shares of Lavipharm SA?

Muslim investors may consider investing in Lavipharm SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Lavipharm SA classified as NOT COVERED?

Musaffa determines the Shariah status of Lavipharm SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Lavipharm SA updated?

The Shariah compliance status of Lavipharm SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Lavipharm SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Lavipharm SA?

You can check the latest Shariah compliance status of Lavipharm SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Lavipharm SA LAVI.AT

Last Updated: Aug 12, 12:00 AM·ASE

Lavipharm SA. Stock Analysis LAVI.AT

Greece Health Care Small Cap

Lavipharm SA engages in the manufacture and import of pharmaceuticals and veterinary products. The company is headquartered in Athina, Attiki and currently employs 285 full-time employees. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. The company is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.